Kirkland Advises Nordic Capital on Acquisition of Majority Share in corpuls

Kirkland & Ellis advised Nordic Capital on the acquisition of a majority share in corpuls | GS Elektromedizinische Geräte G. Stemple GmbH.

The founding family of corpuls is committed to a long-term partnership with Nordic Capital and will remain invested in the company and represented on the management board. The transaction is subject to customary closing conditions, including relevant regulatory approvals with completion being expected at the end of Q2 or the beginning of Q3 2023.

corpuls, founded in 1982 and headquartered in Kaufering, Germany, is a leading global medical technology provider, focusing on high quality and innovative products for professional users in emergency situations. corpuls employs 450 people in total.

Nordic Capital is a leading private equity investor. Focus sectors are Healthcare, Technology & Payments, Financial Services, and selectively, Industrial & Business Services. Since inception in 1989, Nordic Capital has invested EUR 22 billion in over 130 investments.

The Kirkland team advising Nordic Capital was led by corporate partners Benjamin Leyendecker and Sebastian Häfele and included corporate partner Philip Goj; tax partner Michael Ehret; antitrust & competition partner Thomas Wilson; as well as corporate associates Jörg Ruff, Juliane Hubert and Florian Kalbfleisch; tax associates Tobias Stuppi and Florian Schütte; and antitrust & competition associate Sandeep Ravikumar.